Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CRZBY | SMMNY |
|---|---|---|
| Price | $43.85 | $21.07 |
| Change today | ▼ 0.57% | ▼ 1.03% |
| Market cap | $47.67B | $47.66B |
| Return, 3 months | +0.9% | +5.1% |
| Return, year to date | +6.7% | -19.7% |
| Return, 1 year | +21.6% | -25.5% |
| P/E (TTM) | 14.4 | 18.3 |
| P/B | 1.2 | 2.1 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 2.90% | 2.79% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 36 | 39 |
| 30-day volatility | 31.2% | 18.2% |
| Max drawdown, 1 year | -21.6% | -32.8% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
